Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (21)

2023

  1. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  2. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

2022

  1. A Dual Role for FADD in Human Precursor T-Cell Neoplasms

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

  3. S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

    Carcinogenesis, Vol. 40, Núm. 10, pp. 1260-1268

2016

  1. Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival

    British Journal of Cancer, Vol. 115, Núm. 2, pp. 212-222

2014

  1. Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability

    Journal of Investigative Dermatology, Vol. 134, Núm. 1, pp. 247-255

  2. Soluble endoglin antagonizes Met signaling in spindle carcinoma cells

    Carcinogenesis, Vol. 36, Núm. 2, pp. 212-222

  3. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling

    Journal of Biological Chemistry, Vol. 289, Núm. 32, pp. 21960-21972

2013

  1. The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

    Oncogene, Vol. 32, Núm. 20, pp. 2534-2542

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9

  2. Podoplanin associates with cd44 to promote directional cell migration

    Molecular Biology of the Cell, Vol. 21, Núm. 24, pp. 4387-4399

  3. The TGF-β co-receptor endoglin modulates the expression and transforming potential of H-Ras

    Carcinogenesis, Vol. 31, Núm. 12, pp. 2145-2154

  4. The role of the TGF-β coreceptor endoglin in cancer

    TheScientificWorldJournal, Vol. 10, pp. 2367-2384

2008

  1. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas

    Cancer Research, Vol. 68, Núm. 12, pp. 4541-4550

2007

  1. A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas

    Cancer Research, Vol. 67, Núm. 11, pp. 5107-5116

  2. A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis

    Cancer Research, Vol. 67, Núm. 21, pp. 10268-10277

  3. A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas

    EJC SUPPLEMENTS

2005

  1. Characterization of murine S-endoglin isoform and its effects on tumor development

    Oncogene, Vol. 24, Núm. 27, pp. 4450-4461